Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights

Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights

The recent global pandemic due to COVID-19 is caused by a type of coronavirus, SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Despite rigorous efforts worldwide to control the spread and human to human transmission of this virus, incidence and death due to COVID-19 continue to rise. S...

Full description

Bibliographic Details
Main Authors:	Asokan Devarajan, Marmar Vaseghi
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Redox Biology
Subjects:	Chloroquine Hydroxychloroquine Autophagy Oxidative stress Infection immunity Inflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213231720310156

Similar Items

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01)

Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis
by: Yi-Chia Lin, et al.
Published: (2017-05-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Caution of retinal toxicity using chloroquine and hydroxychloroquine in the treatment of COVID-19
by: Li-Yuan Wang, et al.
Published: (2020-07-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2021-12-01)

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
by: Michael Takla, et al.
Published: (2020-12-01)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
by: Yan Chen, et al.
Published: (2020-07-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?
by: Dimitrios P. Bogdanos, et al.
Published: (2019-01-01)

Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
by: A.J.J. Lammers, et al.
Published: (2020-12-01)

Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
by: S. Saqrane, et al.
Published: (2020-05-01)

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
by: Edgard Torres dos Reis Neto, et al.
Published: (2020-06-01)

Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
by: Zhe Chen, et al.
Published: (2021-08-01)

Emerging pharmacotherapies for COVID-19
by: Rachana Salvi, et al.
Published: (2020-08-01)

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
by: Belayneh A
Published: (2020-09-01)

Administration of chloroquine or hydroxychloroquine through feeding tubes: new challenges in times of coronavirus pandemic
by: Mariana Martins Gonzaga do Nascimento, et al.
Published: (2020-04-01)

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
by: Bianza Moise Bakadia, et al.
Published: (2021-01-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021-05-01)

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19
by: Vasilios M. Polymeropoulos
Published: (2020-04-01)

Chloroquine and hydroxychloroquine – safety profile of potential COVID-19 drugs from the rheumatologist’s perspective
by: Dominik Majewski, et al.
Published: (2021-03-01)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
by: Niti Mittal, et al.
Published: (2021-01-01)

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
by: Faizan Mazhar, et al.
Published: (2020-12-01)

Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
by: Pattarawadee Prayuenyong, et al.
Published: (2020-05-01)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
by: Nour K. Younis, et al.
Published: (2020-11-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
by: Sultan Ayoub Meo, et al.
Published: (2020-10-01)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
by: Kome Gbinigie, et al.
Published: (2020-04-01)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
by: Atiya R Faruqui, et al.
Published: (2021-01-01)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01)

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01)

Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies
by: R.L. Schroeder, et al.
Published: (2014-01-01)

Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy
by: Laurel C. Chandler, et al.
Published: (2020-07-01)

Update on hydroxychloroquine retinopathy
by: Remya Mareen Paulose, et al.
Published: (2017-01-01)

Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
by: Tangtavorn N, et al.
Published: (2016-11-01)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
by: Christina B. Klouda, et al.
Published: (2020-09-01)

New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
by: Davide Gentile, et al.
Published: (2020-08-01)

Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis
by: Sourabh Agstam, et al.
Published: (2021-01-01)

Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis
by: Angelos Arfaras-Melainis, et al.
Published: (2021-05-01)

Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19
by: Allan Giri, et al.
Published: (2020-09-01)